| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |